A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Phase 2 study, condition: Overweight or Obesity, CKD, Type 2 Diabetes. The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will last around 31 weeks. Enrolment: 146 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.